Department of Orthodontics, University of Pennsylvania School of Dental Medicine, Philadelphia, Pennsylvania, USA.
Private Practice, Blue Bell, Pennsylvania, USA.
Clin Exp Dent Res. 2023 Dec;9(6):1169-1179. doi: 10.1002/cre2.777. Epub 2023 Oct 6.
Human papillomavirus (HPV) is associated with 70% of oropharyngeal squamous cell carcinomas. Coronavirus disease 2019 (COVID-19) is the infectious cause of a global pandemic that killed millions worldwide. Effective vaccinations exist against both diseases, but patient acceptance remains a challenge. The objective of this study was to assess patients' attitudes toward oral healthcare providers' (OHCPs) roles in HPV and COVID-19 vaccinations.
A cross-sectional survey of young adult patients was distributed in Philadelphia, PA, between April and June 2021. The survey assessed knowledge and attitudes around OHCPs serving various roles in COVID-19 and HPV vaccination.
Nearly 70% of 163 respondents would accept the recommendation for a COVID-19 vaccine from an OHCP, while 56% would for HPV. Those previously vaccinated against COVID-19 were more comfortable discussing COVID-19 vaccines (92%, p < .001) or HPV vaccines (76%, p < .001) with OHCPs compared to those who were unvaccinated against COVID-19. African American/Black patients were less comfortable discussing vaccines, irrespective of vaccination status.
OHCP can play a vital role in increasing the overall COVID-19 and HPV vaccination status of the public, as demonstrated by the high acceptance of dental involvement in both vaccine campaigns. Racial disparity in vaccination attitude is a public health challenge that needs to be addressed.
人乳头瘤病毒（HPV）与 70%的口咽鳞状细胞癌有关。2019 年冠状病毒病（COVID-19）是一种全球性大流行的传染性病因，导致全球数百万人死亡。这两种疾病都有有效的疫苗，但患者的接受程度仍然是一个挑战。本研究的目的是评估患者对口腔保健提供者（OHCP）在 HPV 和 COVID-19 疫苗接种中作用的态度。
2021 年 4 月至 6 月期间，在宾夕法尼亚州费城进行了一项针对年轻成年患者的横断面调查。该调查评估了 OHCP 在 COVID-19 和 HPV 疫苗接种中发挥各种作用的知识和态度。
在 163 名受访者中，近 70%的人会接受 OHCP 推荐 COVID-19 疫苗，而 56%的人会接受 HPV 疫苗。与未接种 COVID-19 疫苗的人相比，之前接种过 COVID-19 疫苗的人更愿意与 OHCP 讨论 COVID-19 疫苗（92%，p<0.001）或 HPV 疫苗（76%，p<0.001）。无论接种疫苗状况如何，非裔美国/黑人患者在讨论疫苗方面都不那么自在。
OHCP 可以在提高公众的 COVID-19 和 HPV 整体疫苗接种率方面发挥重要作用，这从牙科参与这两种疫苗接种活动的高接受率就可以看出。疫苗接种态度的种族差异是一个需要解决的公共卫生挑战。
